You are here

Article Text

Article menu
Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
Chronic fatigue syndrome and complement activation
  1. Robert Dennis Geller1,
  2. Patricia C Giclas2
  1. 1
    FHN, 1045 W Stephenson Street, Freeport, IL 61032, USA
  2. 2
    National Jewish Medical and Research Center, 1400 Jackson, Denver, CO 80206, USA
  1. Robert Dennis Geller, rgeller{at}fhn.org

Summary

This report describes a case of chronic fatigue syndrome (CFS) that followed a well-documented episode of acute Epstein–Barr virus (EBV) mononucleosis. All aetiological tests for chronic fatigue were found to be negative or normal, as were immunological tests. After 2 years of chronic fatigue following the acute illness, measurements of complement split products were performed to test for complement activation. These were positive and remained positive for 14 months, after which the patient then recovered from CFS.

https://doi.org/10.1136/bcr.08.2008.0819

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests: none.

    • Patient consent: Patient/guardian consent was obtained for publication.